Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT03194685
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
97
Enrollment
INDUSTRY
Sponsor class
Conditions
AML, Adult
Interventions
DRUG:
FF-10101-01
Sponsor
Fujifilm Pharmaceuticals U.S.A., Inc.